Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06413797 · ClinicalTrials.gov registry record · NA

Little Cigar and Cigarillo Warnings for Youth

A NA study of Little Cigars and Cigarillos (LCC) Use, sponsored by UNC Lineberger Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
928
Enrollment target
1
Study location

NCT06413797: Completed NA study of Little Cigars and Cigarillos (LCC) Use, sponsored by UNC Lineberger Comprehensive Cancer Center.

NCT06413797 is a NA study of Little Cigars and Cigarillos (LCC) Use that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 928 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06413797, a NA study of Little Cigars and Cigarillos (LCC) Use, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
928 participants
Enrollment target
1
Study location

Study Summary

This study explores the effect of the little cigars and cigarillos (LCC) warnings on youth who currently use, have ever used, or are susceptible to using LCCs. This study will inform the Food and Drug Administration (FDA) implementation of LCC warnings, which can reduce LCC use and lessen tobacco health disparities among youth.

Primary Outcome

The average willingness to use score will be measured by the average of the responses to the 2 survey questions scores. Question Scoring is on a scale of 1 to 5, where 1 indicates low willingness to use LCCs, and 5 indicates a willingness to use LCCs score.

Interventions

  • BEHAVIORAL FDA warnings + Image
  • BEHAVIORAL FDA Warnings Text-Only
  • BEHAVIORAL Surgeon General Text-Only Warnings

Study Locations (1)

North Carolina

  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill

Trial Details

FieldValue
Enrollment Target 928 participants
Start Date 2024-07-18
Est. Completion 2024-11-25
Phase NA

What the finished NCT06413797 record still lists

NCT06413797 is an interventional study that assigns participants to a tested intervention. The registered 928 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (34% lower).

The record links to 1 condition, with Little Cigars and Cigarillos (LCC) Use appearing as the primary indexed condition, and to 3 interventions - of which FDA warnings + Image is the first listed.

NCT06413797 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT06413797 about?

NCT06413797 is a clinical study titled "Little Cigar and Cigarillo Warnings for Youth". This study explores the effect of the little cigars and cigarillos (LCC) warnings on youth who currently use, have ever used, or are susceptible to using LCCs. This study will inform the Food and Drug Administration (FDA) implementation of LCC warnings, which can reduce LCC use and lessen tobacco he...

What is the current status of trial NCT06413797?

This trial is currently completed. It is a NA study. The enrollment target is 928 participants. The study started on 2024-07-18. Estimated completion is 2024-11-25.

What conditions does trial NCT06413797 study?

This clinical trial studies the following conditions: Little Cigars and Cigarillos (LCC) Use.

What interventions are being tested in trial NCT06413797?

The interventions under investigation include: FDA warnings + Image (BEHAVIORAL), FDA Warnings Text-Only (BEHAVIORAL), Surgeon General Text-Only Warnings (BEHAVIORAL).

Who is sponsoring clinical trial NCT06413797?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06413797 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT06413797's enrollment target sits among peer trials

928 123rd of 2000 higher than 1,878 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06378541 · 928 participants · NA

    Smartphone App Enhanced Facilitation Among Veterans in a Mental Health Inpatient Setting (Project HOPE)

  • NCT06555029 · 929 participants · NA

    Oral Health Intervention in Adult Primary Care

  • NCT05216432 · 930 participants · Phase 1

    First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

  • NCT06932029 · 930 participants · NA

    SMBP Study: Improving High Blood Pressure in Older Adults With Multiple Chronic Diseases

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06413797, the US trial registry maintained by the National Library of Medicine. NCT06413797 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.